{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT01999868",
      "orgStudyIdInfo": {
        "id": "ITN053AI",
        "type": null,
        "link": null
      },
      "secondaryIdInfos": [
        {
          "id": "UM1-AI-109565",
          "type": "NIH",
          "domain": "National Institute of Allergy and Infectious Diseases",
          "link": null
        },
        {
          "id": "U24-AI-118663",
          "type": "NIH",
          "domain": "National Institute of Allergy and Infectious Diseases",
          "link": null
        }
      ],
      "organization": {
        "fullName": "Immune Tolerance Network",
        "class": "NETWORK"
      },
      "briefTitle": "Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis",
      "officialTitle": "Psoriasis Treatment with Abatacept and Ustekinumab: a Study of Efficacy (PAUSE) - A Randomized, Double-Blind, Placebo-Controlled Trial to Determine Whether Costimulatory Signaling Blockade With Abatacept Prevents Psoriasis Relapse After Ustekinumab Withdrawal",
      "acronym": "PAUSE"
    },
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": null,
    "armsInterventionsModule": null,
    "outcomesModule": null,
    "eligibilityModule": null
  }
}